Prodia Diagnostic Line is trading 5% down today at IDR 264 as the stock continues to normalize following its recent IPO volatility.
- Shares are experiencing renewed weakness as part of an ongoing post-listing adjustment, following heavy profit-taking that succeeded the initial July IPO surge.
- The current decline follows a brief rebound on July 28, suggesting today's price action is a continuation of the stock's normalization process rather than a reaction to fresh company news.